Table 1.
Characteristics | All Patients (n = 57) | HM2 (n = 44) | HVAD (n = 13) | P Value |
---|---|---|---|---|
General characteristics | ||||
Age, y, mean ± SD | 58.1 ± 11.5 | 59.4 ± 11.1 | 53.3 ± 11.8 | .09 |
Male, % | 71.9 | 72.7 | 69.2 | 1.0 |
Origin of cardiomyopathy, % | .53 | |||
Ischemic | 50.9 | 47.7 | 61.5 | |
Nonischemic | 49.1 | 52.3 | 38.5 | |
LVAD characteristics | ||||
Duration of LVAD, mo, mean ± SD | 18.4 ± 19.0 | 20.4 ± 20.1 | 11.8 ± 12.8 | .15 |
Destination, %: | .03 | |||
BTT | 28.1 | 20.5 | 53.8 | |
DT | 71.9 | 79.5 | 46.2 | |
Average speed, rpm, mean ± SD | NA | 9158 ± 392 | 2695 ± 134 | <.0001 |
Medical history, % | ||||
Hypertension | 61.4 | 65.9 | 46.1 | .21 |
Hyperlipidemia | 43.9 | 40.9 | 53.8 | .53 |
Atrial fibrillation | 26.3 | 31.8 | 7.7 | .15 |
DM | 38.6 | 34.1 | 53.8 | .22 |
COPD | 14.0 | 15.9 | 7.7 | .67 |
PAD | 10.5 | 9.1 | 15.4 | .61 |
CVA, % | 22.8 | 18.2 | 38.4 | .15 |
Prior sternotomy | 22.8 | 18.2 | 38.4 | .15 |
HM2, Heartmate II; HVAD, Heartware HVAD; BTT, bridge to transplant; DT, destination therapy; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; PAD, peripheral artery disease; CVA, cardiovascular accident;